4 recruiting, 3 not yet recruiting, 1 terminated. 4 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow RCC, Renal Cell Cancer: new trials by email Literature Review of RCC, Renal Cell Cancer trials Research Report on RCC, Renal Cell Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors. Signatera Genome ultra-sensitive ctDNA blood test - NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer) | Not applicable | Not yet recruiting | Natera, Inc. | 920 | 2026-12-01 | 2026-08-04 |
| Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy Iparomlimab and Tuvonralimab Injection in combination with Lenvatinib or Axitinib - RCC, Renal Cell Cancer | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 36 | 2026-02-15 | 2025-12-11 |
| Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis Blood sample collection - Non Small Cell Lung Cancer (NSCLC), Melanoma (Skin Cancer) | Not yet recruiting | OncoHost Ltd. | 600 | 2025-11-15 | 2025-11-24 | |
| Comparison of Outcomes and Surgical Time Between Cortical and Medullary Suture vs. Medullary-Only Suture: Cortex Clinical Trial Medullary-only suturing (single-layer), Suture, Medullary and cortical suturing (two-layer) - RCC, Renal Cell Cancer | Not applicable | Recruiting | Brazilian Institute of Robotic Surgery | 80 | 2025-07-23 | 2025-09-24 |
| A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. LXP1788 is administered intravenously via Port-A - Solid Tumor Malignancies, Cancer, Solid Cancers | Phase 1 | Recruiting | LaunXP Biomedical Co., Ltd. | 24 | 2024-12-31 | 2025-03-19 |
| Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors partial nephrectomy with main or branch renal artery clamping, partial nephrectomy with zero renal artery clamping - RCC, Renal Cell Cancer, Partial Nephrectomy | Not applicable | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 60 | 2024-12-01 | 2025-04-03 |
| A Study Evaluating the Value of 68Ga-NOTA-RCCB6 PET Imaging for Targeting CD70 in the Clinical Staging, Therapeutic Evaluation, and Restaging of Renal Cell Carcinoma, and Comparing It with 68Ga-PSMA PET/CT Imaging 68Ga-NOTA-RCCB6 PET/CT Scan - RCC, Renal Cell Cancer | Not applicable | Recruiting | Xijing Hospital | 60 | 2024-06-12 | 2025-01-10 |
| A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma NIR178, PDR001 - NSCLC, Non Small Cell Lung Cancer, RCC, Renal Cell Cancer | Phase 2 | Terminated | Novartis Pharmaceuticals | 315 | 2017-08-28 | 2024-10-09 |
Carcinoma, Renal Cell (8) · Carcinoma, Non-Small-Cell Lung (3) · Melanoma (3) · Pancreatic Neoplasms (2) · Triple Negative Breast Neoplasms (2) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Spinocerebellar Degenerations (1) · Squamous Cell Carcinoma of Head and Neck (1)
Adenocarcinoma (8) · Carcinoma (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Kidney Diseases (8) · Kidney Neoplasms (8) · Male Urogenital Diseases (8) · Neoplasms by Histologic Type (8) · Neoplasms by Site (8) · Neoplasms, Glandular and Epithelial (8) · Urogenital Diseases (8) · Urogenital Neoplasms (8) · Urologic Diseases (8) · Urologic Neoplasms (8) · Neoplasms (7)
Axitinib (1) · Sutures (1) · lenvatinib (1) · spartalizumab (1)
Brazilian Institute of Robotic Surgery (1) · LaunXP Biomedical Co., Ltd. (1) · Natera, Inc. (1) · Novartis Pharmaceuticals (1) · OncoHost Ltd. (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Xijing Hospital (1)
China (2) · Germany (2) · Italy (2) · Spain (2) · Taiwan (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Czechia (1) · France (1) · Japan (1) · Netherlands (1) · Singapore (1)
Caitlin Shonewolf, MD (1) · Xin Yao (1)
2017 (1)